Measurement of health-related quality of life with glaucoma: Validation of the Glau-QoL © 36-item questionnaire

Acta Ophthalmologica

Volumn 86, Issue 1, 2008, Pages 71-80

  Béchetoille, Alain ^a   Arnould, Benoit ^b   Bron, Alain ^c   Baudouin, Christophe ^d   Renard, Jean Paul ^e   Sellem, Eric ^f   Brouquet, Yves ^g   Denis, Philippe ^h   Nordmann, Jean Philippe ^d   Rigeade, Marie Claude ⁱ   Bassols, Ana ^g   Benmedjahed, Khadra ^b   Guillemin, Isabelle ^b   Rouland, Jean François ^j  

^a Ophthalmological Practice   (France)

^b MAPI VALUES   (United States)

^c General Hospital   (France)

^d CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

^e University of Paris Descartes   (France)

^f Centre Ophtalmologique Kleber   (France)

^g Bausch and Lomb   (France)

^h EDOUARD HERRIOT HOSPITAL   (France)

ⁱ Ophthalmological Practice   (France)

^j LILLE UNIVERSITY HOSPITAL   (France)

more..

Author keywords

Health related quality of life; Ocular hypertension; Primary open angle glaucoma; Psychometric validation; Questionnaire

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBONATE DEHYDRATASE INHIBITOR; EYE DROPS; PROSTAGLANDIN DERIVATIVE;

ADULT; AGED; AGING; ANXIETY; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DAILY LIFE ACTIVITY; DISCRIMINANT VALIDITY; DISEASE SEVERITY; DRIVING ABILITY; FEMALE; GLAUCOMA; GLAUCOMA SPECIFIC HEALTH RELATED QUALITY OF LIFE QUESTIONNAIRE; HUMAN; INTERVIEW; INTRAOCULAR HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; REPRODUCIBILITY; SCORING SYSTEM; SELF CONCEPT; VALIDATION STUDY; VISUAL ACUITY; VISUAL FIELD DEFECT; CAR DRIVING; CROSS-SECTIONAL STUDY; HEALTH STATUS; MENTAL HEALTH; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; STANDARD;

ACTIVITIES OF DAILY LIVING; AGED; AUTOMOBILE DRIVING; CROSS-SECTIONAL STUDIES; FEMALE; GLAUCOMA; HEALTH STATUS; HUMANS; MALE; MENTAL HEALTH; MIDDLE AGED; OCULAR HYPERTENSION; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SELF CONCEPT;

EID: 39349091500     PISSN: 1755375X     EISSN: 16000420     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2007.00999.x     Document Type: Article

References (40)

1. Arnould B (2006): Patient-reported outcomes in clinical practice. From measurement instruments to decision tools: Much more than a single change in format. PRO Newsletter 36: 21-24.
2. Barber BL, Strahlman ER, Laibovitz R, Guess HA & Reines SA (1997): Validation of a questionnaire for comparing the tolerability of ophthalmic medications. Ophthalmology 104: 334-342. [Erratum: Ophthalmology 104: 890 -893.]
3. Baudouin C, Béchetoille A, Bron A et.al. (2000): Intérêt de la mesure de la qualitéde vie (QDV) et de l'observance thérapeutique chez les patients atteints de glaucome chronique àangle ouvert. J Fr Ophtalmol 23: 1057-1064.
4. Béchetoille A (1987): Glaucomes. Angers: Japperenard 221-222 and 589 -596.
5. Brodersen J, McKenna SP, Doward LC & Thorsen H (2007): Measuring the psychosocial consequences of screening. Health Qual Life Outcomes 5: 3.
6. Campbell DT & Fiske JL (1959): Convergent and discriminant validation by the multitrait-multimethod matrix. Psychol Bull 56: 85-105.
7. Chassany O, Sagnier P, Marquis P, Fullerton S & Aaronson N (2002): Patient-reported outcomes. The example of health-related quality of life: A European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Inf J 36: 209-238.
8. Cronbach LJ (1951): Coefficient alpha and the internal structure of tests. Psychometrika 16: 297-334.
9. Deyo RA, Diehr P & Patrick DL (1991): Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. Control Clin Trials 12 (Suppl): 142-158.
10. Guyatt GH, Walter S & Norman G (1987): Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis 40: 171-178.
11. Hattenhauer MG, Johnson DH, Ing HH, Herman DC, Hodge DO, Yawn BP, Butterfield LC & Gray DT (1998): The probability of blindness from open-angle glaucoma. Ophthalmology 105: 2099-2104.
12. Hays RD, Anderson RT & Revicki D (1998): Assessing reliability and validity of measurement in clinical trials. In: Staquet MJ, Hays RD & Fayers PM (eds). Quality of Life Assessment in Clinical Trials. New York: Oxford University Press 169-182.
13. Herndon LW & Durham NC (2004): Communication is the cornerstone of glaucoma treatment. Glaucoma management perspectives. [Second in a series of four.] Ophthalmol Manag (in press).
14. Hoevenaars JG, Schouten JS, van den Borne B et.al. (2006): Socioeconomic differences in glaucoma patients' knowledge, need for information and expectations of treatments. Acta Ophthalmol Scand 84: 84-91.
15. Hosoda M, Yamabayashi S, Furuta M et.al. (1995): Do glaucoma patients use eyedrops correctly? J Glaucoma 4: 202-206.
16. Janz NK, Wren PA, Lichter PR et.al. (2001): Quality of life in newly diagnosed glaucoma patients. The Collaborative Initial Glaucoma Treatment Study. Ophthalmology 108: 887-897; discussion 898.
17. Juniper EF, Guyatt GH & Jaeschke R (1996): How to develop and validate a new health-related quality of life instrument? In: Spilker B (ed). Quality of Life and Pharmacoeconomics in Clinical Trials, 2nd edn. Philadelphia: Lippincott-Raven 49-56.
18. Kobelt G, Jönsson B, Bergström A et al. (2006): Cost-effectiveness analysis in glaucoma: What drives utility? Results from a pilot study in Sweden. Acta Ophthalmol Scand 84: 363-371.
19. Kroese M, Burton H, Vardy S, Rimmer T & McCarter D (2002): Prevalence of primary open-angle glaucoma in general ophthalmology practice in the United Kingdom. Br J Ophthalmol 86: 978-980.
20. Landers MB (1982): Glaucoma. Philadelphia: WB Saunders.
21. Lee BL & Wilson MR (2000): Health-related quality of life in patients with cataract and glaucoma. J Glaucoma 9: 87-94.
22. Lindblom B, Nordmann JP, Sellem E et al. (2006): A multicentre, retrospective study of resource utilization and costs associated with glaucoma management in France and Sweden. Acta Ophthalmol Scand 84: 74-83.
23. Lohr KN, Aaronson NK, Alonso J et al. (1996): Evaluating quality-of-life and health status instruments: Development of scientific review criteria. Clin Ther 18: 979-992.
24. McCaffery KJ & Barratt AL (2004): Assessing psychosocial/quality of life outcomes in screening: How do we do it better? J Epidemiol Community Health 58: 968-970.
25. Naacke H & Baudouin C (1999): Le patient glaucomateux et son traitement: Qu'en est-il réellement? Les pièges de la maladie glaucomateuse. J Fr Ophtalmol 22: 99-101.
26. Nelson P, Aspinall P, Papasouliotis O, Worton B & O'Brien C (2003): Quality of life in glaucoma and its relationship with visual function. J Glaucoma 12: 139-150.
27. Nordmann JP, Viala M, Sullivan K et al. (2004): Psychometric validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) French version in a population of patients treated for ocular hypertension and glaucoma. Pharmacoeconomics 22: 197-206.
28. Nunnally JC & Bernstein IH (1994): The assessment of reliability. In: Psychometric Theory, 3rd edn. New York: McGraw-Hill, Inc. 248-292.
29. Odberg T, Jakobsen JE, Hultgren SJ & Halseide R (2001): The impact of glaucoma on the quality of life of patients in Norway. I. Results from a self-administered questionnaire. Acta Ophthalmol Scand 79: 116-120.
30. Patrick DL, Burke LB, Powers JH, Scott JA, Rock EP, Dawisha S, O'Neil R & KePnedy DL (2007): FDA guidance: patient-reported outcomes to support medical product labelling claims (unpublished).
31. Patrick DL & Deyo RA (1989): Generic and disease-specific measures in assessing health status and quality of life. Med Care 27: S217-S232.
32. Rotchford AP & Murphy KM (1998): Compliance with timolol treatment in glaucoma. Eye 12: 234-236.
33. Rouland JF, Denis P, Béchetoille A & Groupe d'Étude Glaucome et Qualitéde Vie (Glaucoma and Quality of Life Study Group) (2002): Création d'un questionnaire spécifique évaluant la qualitéde vie chez les patients glaucomateux: la génération des items. J Fr Ophtalmol 25: 785-794.
34. Schipper H (1990): Guidelines and caveats for quality of life measurement in clinical practice and research. Oncology (Williston Park) 4: 51-57.
35. Sloane ME, Ball K, Owsley C, Bruni JR & Roenker DL (1992): The Visual Activities Questionnaire: Developing an instrument for assessing problems in everyday visual tasks. Tech Dig Non-invasive Assess Vis Sys 1: 26-29.
36. Spilker B (1990): Introduction to the field of quality of life trials. In: Spilker B (ed). Quality of Life Assessment in Clinical Trials. New York: Raven Press 3-10.
37. Steinberg EP, Tielsch JM, Schein OD et al. (1994): The VF-14. An index of functional impairment in patients with cataract. Arch Ophthalmol 112: 630-638.
38. Stewart AL, Hays RD & Ware J (1992): Methods of validating MOS health measures. In: Stewart AL & Ware JE (eds). Measuring Functioning and Wellbeing: The Medical Outcomes Study Approach. Durham, NC: Duke University Press 309-324.
39. World Health Organization Quality of Life (WHOQoL) Assessment Group (1998): Development and general psychometric properties. Soc Sci Med 46: 1569-1585.
40. Zanlonghi X, Arnould B, Béchetoille A et al. (2003): Glaucome et qualitéde vie. J Fr Ophtalmol 26 (Suppl): 39-44.